Object. The authors of this preliminary study investigated the outcome and feasibility of intraoperative microelectrode recording (MER) in patients with Parkinson disease (PD) undergoing deep brain stimulation of the subthalamic nucleus (STN) after anesthetic inhalation.
M
icroelectrode recording for verification of distinct neuronal firing during DBS of the STN in patients with advanced PD is recognized as an effective procedure to improve outcome. 3 Patterns of STN neuronal firing are significantly different from the cells of the overlying zona incerta and the underlying SNr. This can be observed both on the increased background activity of the nucleus and bursting single cell activity of spontaneously active neurons within the nucleus. 19, 23 Although detailed MER mapping within the STN may lead to optimal placement of DBS electrodes, the patient must be kept awake during this time-consuming procedure. Some patients with severe "off-medication" PD symptoms, such as major anxiety, poorly tolerated off-medication dystonia, or respiratory difficulties may refuse to undergo DBS, or they may not be considered appropriate candidates for DBS while awake. 5, 13 Deep brain stimulation of the STN with the patient in a state of general anesthesia may be an option for patients with advanced PD in whom symptoms are medically intractable. The aim of this preliminary study was to determine whether MER could be used as an adjunct during DBS of the STN while the patient receives a light inhalation anesthetic, and whether the results would be comparable to those achieved with the use of a local anesthetic.
Methods

Patient Selection
Ten patients who received a desflurane anesthetic during bilateral STN electrode implantation for PD at our institution between March 2004 and December 2004 were included in this retrospective study. These patients included 2 women and 8 men with a mean age (± SD) of Subthalamic deep brain stimulation after anesthetic inhalation in Parkinson disease: a preliminary study 58.9 ± 9.86 years, and a mean disease duration of 8.8 ± 3.65 years. The mean Hoehn and Yahr Stage score was 3.35 ± 0.75, and the mean daily levodopa equivalent dose was 950 ± 271.31 mg. All included patients met the United Kingdom Parkinson's Disease Brain Bank diagnostic criteria in that at least 2 of the cardinal symptoms were present. 6 Before surgery each patient underwent a levodopa test to ensure a positive levodopa response. 3 Brain MR imaging was performed preoperatively in each patient to rule out structural abnormalities. The same surgical team performed all DBS procedures in the patients.
Imaging and Targeting
Magnetic resonance images of the STN were obtained with a 1.5-T MR unit (General Electric). The standard settings comprised T1-weighted axial images of 0.75-mm thickness, T2-weighted axial images of 2-mm thickness, and T2-weighted coronal images of 3-mm thickness. Each sequence was performed in contiguous slices. The images were transferred in a Digital Image Communications in Medicine database through the Picture Archiving and Communicating System to the BrainLab VectorVision neuronavigation workstation. Image fusion software was used to fuse the 3 sets of MR images for 3D reconstruction. The tentative surgical target coordinates for the tip of the permanent implantable electrode were set at the central lowest border of the STN by direct visualization on MR imaging, as previously described. 
Stereotactic Procedure
A Leksell G-frame unit (Elekta Instruments, Inc.) was used for the stereotactic procedure. The patient rested comfortably on the operating table in a semi-Fowler position with the head frame secured in a Mayfield adaptor. The target coordinates were applied to the stereotactic frame and the working stage. After the MER data was obtained, the permanent electrodes were implanted.
Anesthetic Procedure
All patients received a general anesthetic agent via endotracheal intubation. Anesthesia was induced by administration of regular narcotic agents and a muscle relaxant, and maintained by desflurane inhalation throughout surgery. The depth of anesthesia was monitored by the patient's heart rate and blood pressure. The MAC was maintained at ~ 0.5-1 during the procedure so that the patient would not experience a gag reflex or any change in heart rate or blood pressure.
Microelectrode Recording Procedure
The MER device is 10-40 µm in diameter, and measures 200 mm in length with a 10-mm-long, bare tungsten tip. The recording impedance was 0.5-1 MΩ. The microelectrode was mounted on a microdriver, from which it was sent into the target, the STN. The signal obtained from the tip of the microelectrode was sent to the intraoperative microrecording system (Axon Guideline 3000A, FHC) where it was magnified and displayed. The discharge from each neuron was recorded for 20 seconds and the recording was saved to the system hard disk for off-line analysis. Neuronal spikes were sorted by Offline Sorter (Plexon) for neuronal firing rate and amplitude measurement. In a typical trajectory to the STN, the microelectrode passed through the thalamus, the zona incerta, the STN, and the underlying SNr. Passive movement of the contralateral limbs was tested during the MER procedure in the STN to see if there had been movementrelated neuronal firing changes. Neurons were regarded as movement-related if there was audible alteration in the neuronal discharge that was reproducible and synchronous with the passive movement. 1, 24 To shorten the surgical time, we tested the movement-related STN neurons in the first 2 mm of the STN because these cells were found mostly in the dorsolateral part of the STN. 24 The selection of the final trajectory for electrode implantation depended on the length of STN firing, which had to be at least 4.5 mm, and on the presence of arm and/or leg passive movement related to the STN neuron (Fig. 1) . If the length of STN firing in each trajectory was not ≥ 4.5 mm after multiple trajectories, the tract with the longest STN signals was selected as the final trajectory for electrode implantation. Stereotactic intraoperative fluoroscopy was performed to record the tip position of the microelectrode, which served as a reference point for final electrode implantation. We did not perform any test stimulations after permanent implantation. All 10 patients received final electrode implantation with Medtronic 3387 DBS leads.
Postoperative Course
The endotracheal tube was removed after the electrode was implanted. Computed tomography scanning of the brain was performed in 1.25-mm consecutive slices before the patient was removed from the operating room. Computed tomography scans were obtained to exclude intracranial complications and evaluate the initial postoperative electrode coordinates through image fusion with the preoperative MR images. The final electrode coordinates were confirmed on MR images obtained within 3 months of the procedure's completion. The Kinetra neu rostimulator (Medtronic) was implanted 1 week after elec trode implantation.
Outcome Analysis
We conducted follow-up visits with all patients 6 months after implantation. At the time of follow-up, each patient was evaluated with the UPDRS under 4 different conditions: on and off medication and with and without DBS. The off-medication condition was defined as patient not taking antiparkinsonian medication for at least 12 hours. The without DBS condition was defined as the patient not receiving DBS for 4 hours, or the time of tolerance of the patient (sometimes < 4 hours, but at least 1 hour).
To evaluate the effect of STN DBS, we compared the UPDRS scores in patients in the postoperative off-medication but with DBS condition with the scores obtained in patients in the preoperative off-medication condition. The improvement was the percentage of change in the difference between the UPDRS scores in patients under these 2 conditions, and the percentage was corrected to preopera-tive off-medication values. The improvement in preoperative baseline was defined as the percentage by which the UPDRS score changed when the patient was in best onmedication condition and worst off-medication condition (after at least a 12-hour interruption of medication).
Statistical Analysis
All data are expressed as means ± SDs. Paired ttests were used as necessary for comparisons between 2 groups. Statistical significance was set at a probability value of < 0.05 for all tests.
Results
Surgical Outcome
The patients were followed up for 8.9 ± 2.92 months. No intracerebral hemorrhage was found in any patient. Transient postoperative confusion was observed in 1 patient, but this resolved 2 days later. No capsular effects under low voltage (< 4 V) were noted. The mean postoperative DBS parameters in our patients were as follows: 3.24 ± 0.38 V, 60 ± 0 µsec in pulse width, and 151.5 ± 18 Hz. Monopolar stimulation with Contact 1 (55%) or 2 (45%) was used in all 10 patients. The mean daily levodopa-equivalent dose was decreased from 950 ± 271.31 mg preoperatively to 293.75 ± 131.93 mg postoperatively-a decrease of 66.36 ± 17.62%. The mean UPDRS total and motor (Part III) scores at the preoperative baseline were 82.6 ± 24.2 and 50.2 ± 12.9, respectively, and the mean improvement in UPDRS total and motor scores was 32.34 ± 16.27% and 35 ± 12.42%, respectively. In the postoperative off-medication/with DBS state, the mean UPDRS total and motor scores were 39 ± 25.2 and 25.6 ± 11.68, which were both significantly lower than preoperative baseline values (p < 0.05). The mean improvement in total and motor UPDRS scores was 54.27 ± 17.96% and 48.85 ± 16.97%, respectively. The mean Hoehn and Yahr Stage score was 2.85 ± 0.82, a significant improvement over the preoperative baseline (p < 0.05; Table 1 ).
Measurement of MER
The mean number of MER trajectories for each electrode implantation were 1.55 ± 1.00. The mean length of STN recording was 4.87 ± 0.49 mm (right side) and 5.05 ± 0.56 mm (left side). A total of 227 STN neurons were detected and recorded, and 40 movement-related neurons (17.6%) were found in the 10 patients. The mean STN neuronal firing rate was 29.7 ± 14.6 Hz, and the mean amplitude of STN neurons was 380.5 ± 105.4 µV ( Table 2) . Although all patients received the light desflurane anesthetic, the typical firing pattern of STN and SNr neurons was observed (Fig. 2) . The mean pre-and postoperative functional target coordinates at the midpoint of the anterior and posterior commissure were as follows: x = 11.25 ± 0.61 and 10.85 ± 1.20, respectively; y = -3.41 ± 0.65 and -3.67 ± 1.48, respectively; and z = -5.65 ± 0.60 and -6.90 ± 1.66, respectively ( Table 3 ). The z coordinate was significantly different between pre-and postoperative coordinates (p < 0.05).
Discussion
In this retrospective study we found that the parkin- sonian symptoms markedly improved in patients in whom an inhalation anesthetic and MER were used during DBS procedures. The surgical outcome in our patients was comparable to that reported in the literature concerning patients who underwent DBS surgery while receiving a local anesthetic. 10, 18, 21 To the best of our knowledge, there are only 2 other reports on the outcome of patients who received a general anesthetic for bilateral STN DBS surgery. 5, 13 Our results are compatible with these 2 previous reports.
There are some differences worth noting between our report and those of other authors. 5, 13 First, the anesthetic method used in the 2 reports is different from ours: intravenously administered propofol anesthetic was used instead of the desflurane that was used in our patients. Second, the authors used simultaneous multiple-track MER, while we performed simultaneous single-track MER. Third, in the study by Hertel and colleagues, 5 test stimulation was performed to verify the possible capsular side effect of electrode stimulation. As in our study, Maltete and colleagues 13 did not perform test stimulation after permanent electrode implantation.
In the present report, the mean neuronal discharge rate in the STN was 29.7 ± 14.6 Hz, which is near the lower limit of the mean firing rate of STN neurons in patients with PD who undergo surgery in the awake state (33-46 Hz). 7, 11, 17 This result is consistent with the results in a previous report in which desflurane attenuated the firing rate of pallidal neurons. 20 In the report by Hertel and colleagues, 5 the mean firing rate of STN neurons in patients who received intravenous propofol was 40 Hz (25-50 Hz) . In this anesthetic procedure, propofol levels were lowered as far as possible for MER. The depressive effect of propofol on pallidal neuronal firing has been reported by Hutchison and coworkers, 8 who argued that the effect was related to the concentration of this anesthetic agent. In contrast, Steigerwald et al. 22 reported that the estimated plasma concentration of propofol did not have a consistent effect on pallidal activity in patients with dystonia. Firm conclusions about the effects of desflurane or propofol therapy on STN neurons cannot be made from these limited data; however, maintaining a low concentration of anesthetic agents during surgery is a good practice as no obvious change in MER status could be found. The typical burst firing pattern of STN neurons can be observed during MER in patients who underwent anesthesia with intravenously administered propofol or light desflurane anesthesia (Fig. 2) . 5 Changes in firing patterns were significant enough to be recognized from the borders of the STN. This increases the feasibility of MER while the patient is in a state of general anesthesia.
Movement-related neuronal firing can be recorded in awake, nonsedated patients by passive manipulation of contralateral limbs. 1, 12, 24 In our patients in whom light desflurane anesthesia was induced, passive movement-related neuronal activity could be observed in a good MER trajectory. The percentage of movement-related STN neurons (17.6%) in our patients was smaller than that in previous studies (~ 50%).
1, 24 Because we did not test the passive movement of limbs completely during MER, our finding of fewer movement-related cells could be the ef- fect of anesthesia or, as we tested only the upper 2 mm of the STN trajectory intraoperatively, an incomplete test of movement-related cells in the STN. The dorsolateral part of STN was the predominant location of the movement-related neurons. Most of the leg-related STN neurons were located centromedially, whereas the armrelated cells were centrolateral and at the rostral and caudal poles. 24 A tract with arm and leg movement-related neurons may suggest that the trajectory passes through the central portion of dorsolateral STN and is appropriate for electrode implantation. The most useful criteria to select a trajectory postulated by Benazzouz et al.
2 were: 1) the length of an individual trajectory displaying typical STN activity, 2) the burst pattern of the activity, and 3) the motor responses typical of the sensorimotor part of the nucleus. In a patient in a light desflurane anesthesia state, the selection of the microelectrode track with the presence of movement-related STN neurons and a signal length > 4.5 mm ensures more accurate targeting, which may predict good motor improvement after electrode implantation.
In our study, maintaining the MAC < 1 during desflurane anesthesia was critical for the performance of MER. Desflurane is the newest derivative of isoflurane; it is popularly applied in neurosurgical procedures with better cerebral pharmacokinetic and pharmacodynamic character than other volatile anesthetics. A dose-dependent suppressive effect on amplitude in spinal somatosen- sory-evoked potentials in rats that have been anesthetized with desflurane has been reported. 9 Anesthesia with desflurane depresses the discharge rate of the globus pallidus externa and globus pallidus interna neurons, particularly in patients with PD.
20 Therefore, keeping the MAC < 1 with a low desflurane concentration will attenuate the depressive effect of desflurane on the MER.
The role of MER in DBS surgery remains controversial. Patel and coworkers 14, 15 reported that MR imagingdirected targeting methods for implantation of DBS leads into the STN can be used safely and effectively. Authors of other reports have shown that intraoperative MER is of significant importance for accurate STN localization. 2, 3, 16, 23 Although the difference in pre-and postoperative target coordinates was only statistically significant on the z axis in our study, the changes in x and y coordinates after MER reached 2.1 and 2.8 mm in our patients (Table 3) . A > 2-mm difference in x or y coordinates after MER was found in 5 electrodes (25% of electrodes). The correction of target coordinates by MER during DBS surgery may be helpful in achieving a better surgical outcome and in reassuring the surgeon that the electrode was implanted accurately under general anesthesia. In our experience, a combination of anatomical and neurophysiological targeting will ensure a better outcome in patients with bilateral STN stimulation. 3 We are not aware of any studies designed to compare the serial approach of MER mapping with simultaneous multiple track MER mapping. In a review article, Gross and colleagues 4 compared reports from > 40 surgical centers and found that the improvement in motor scores of patients in whom multiple track MER mapping was used was not different from those in whom serial MER mapping was performed. Therefore, no definitive conclusions can be made on this issue. Both strategies in MER mapping can achieve a good surgical outcome. The choice of MER mapping methods is dependent on the chosen MER hardware system and the experience of the surgical team.
In patients with advanced PD who undergo DBS surgery in the STN consciously sedated, test stimulation after permanent electrode implantation is helpful for confirming the position of the electrode. The test stimulation verifies the maximal clinical effects intraoperatively as well as the side effects of low voltage if the electrode position is not optimal. The role of test stimulation in patients who receive general anesthesia is controversial. In their study, Hertel et al.
5 performed test stimulation to verify possible capsular effects in low-voltage electrode stimulation; the voltage causing capsular effects could be incorrectly estimated if the excitability of the capsule was decreased under general anesthesia. In our study, no patient suffered capsular side effects postoperatively because our selection criteria of trajectory for electrode implantation were good enough to choose the most appropriate tract.
This preliminary study has 2 limitations: the small number of included patients, and the retrospective nature of our study. The number of included patients in our series is small compared with that in other series in which patients underwent surgery under conscious sedation. Enrollment of more patients in future studies may confirm the consistency of our results, or show some differences between local and light desflurane anesthetic groups. The second limitation in our study is its retrospective nature, with patient enrollment being restricted to those who strongly feared surgery or whose off-medication symptoms were extremely pronounced. Well-designed, prospective studies in which the outcomes in patients with PD who undergo DBS while receiving a local anesthetic are compared to those receiving general anesthesia with desflurane are needed.
Conclusions
Based on our results, MER can be performed while the patient receives a light desflurane anesthetic and the MER results can provide final guidance for STN electrode implantation. This can be an alternative method useful in patients unable to bear this type of surgery while awake. 
